| Product Code: ETC11388271 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Antibody Mediated Rejection Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Antibody Mediated Rejection Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Antibody Mediated Rejection Market - Industry Life Cycle |
3.4 Israel Antibody Mediated Rejection Market - Porter's Five Forces |
3.5 Israel Antibody Mediated Rejection Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 Israel Antibody Mediated Rejection Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.7 Israel Antibody Mediated Rejection Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Israel Antibody Mediated Rejection Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of antibody-mediated rejection cases in Israel |
4.2.2 Advancements in diagnostic technologies for early detection of antibody-mediated rejection |
4.2.3 Growing investments in research and development for antibody-mediated rejection treatments |
4.3 Market Restraints |
4.3.1 High cost associated with antibody-mediated rejection diagnosis and treatment |
4.3.2 Limited awareness among healthcare professionals and patients about antibody-mediated rejection |
4.3.3 Stringent regulatory requirements for approval of new antibody-mediated rejection therapies |
5 Israel Antibody Mediated Rejection Market Trends |
6 Israel Antibody Mediated Rejection Market, By Types |
6.1 Israel Antibody Mediated Rejection Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Antibody Mediated Rejection Market Revenues & Volume, By Treatment Type, 2021 - 2031F |
6.1.3 Israel Antibody Mediated Rejection Market Revenues & Volume, By Plasmapheresis, 2021 - 2031F |
6.1.4 Israel Antibody Mediated Rejection Market Revenues & Volume, By IVIG, 2021 - 2031F |
6.1.5 Israel Antibody Mediated Rejection Market Revenues & Volume, By Rituximab, 2021 - 2031F |
6.1.6 Israel Antibody Mediated Rejection Market Revenues & Volume, By Bortezomib, 2021 - 2031F |
6.2 Israel Antibody Mediated Rejection Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 Israel Antibody Mediated Rejection Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.2.3 Israel Antibody Mediated Rejection Market Revenues & Volume, By Transplant Centers, 2021 - 2031F |
6.2.4 Israel Antibody Mediated Rejection Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.3 Israel Antibody Mediated Rejection Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Israel Antibody Mediated Rejection Market Revenues & Volume, By Kidney Transplant, 2021 - 2031F |
6.3.3 Israel Antibody Mediated Rejection Market Revenues & Volume, By Heart Transplant, 2021 - 2031F |
6.3.4 Israel Antibody Mediated Rejection Market Revenues & Volume, By Liver Transplant, 2021 - 2031F |
7 Israel Antibody Mediated Rejection Market Import-Export Trade Statistics |
7.1 Israel Antibody Mediated Rejection Market Export to Major Countries |
7.2 Israel Antibody Mediated Rejection Market Imports from Major Countries |
8 Israel Antibody Mediated Rejection Market Key Performance Indicators |
8.1 Average time to diagnosis of antibody-mediated rejection cases |
8.2 Number of clinical trials for antibody-mediated rejection therapies in Israel |
8.3 Adoption rate of new diagnostic technologies for antibody-mediated rejection |
9 Israel Antibody Mediated Rejection Market - Opportunity Assessment |
9.1 Israel Antibody Mediated Rejection Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 Israel Antibody Mediated Rejection Market Opportunity Assessment, By End User, 2021 & 2031F |
9.3 Israel Antibody Mediated Rejection Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Israel Antibody Mediated Rejection Market - Competitive Landscape |
10.1 Israel Antibody Mediated Rejection Market Revenue Share, By Companies, 2024 |
10.2 Israel Antibody Mediated Rejection Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here